CStone Pharmaceuticals (HKG:2616)
Hong Kong · Delayed Price · Currency is HKD 10.02
-0.21 (-2.05%)
Apr 17, 2026, 3:30 PM HKT
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of 15.06 billion as of April 16, 2026. Its market cap has increased by 232.36% in one year.
Market Cap
15.06B
Enterprise Value
14.38B
Revenue
299.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.02
Market Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has increased from 12.65B to 15.06B, an increase of 19.03%. That is a compound annual growth rate of 2.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 15.06B | 94.12% |
| Dec 31, 2025 | 7.76B | 164.29% |
| Dec 31, 2024 | 2.94B | 1.52% |
| Dec 29, 2023 | 2.89B | -47.58% |
| Dec 30, 2022 | 5.52B | -42.71% |
| Dec 31, 2021 | 9.63B | -16.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Keymed Biosciences | 21.89B |
| Zai Lab | 18.83B |
| Ascletis Pharma | 18.57B |
| Ascentage Pharma Group International | 18.06B |
| Nanjing Leads Biolabs | 17.67B |
| Everest Medicines | 13.35B |
| HBM Holdings | 11.57B |
| CARsgen Therapeutics Holdings | 10.45B |